GGrantIndex
← Leaderboards

Gary S Lynch

University Of California Irvine

Google Scholar ↗PubMed ↗ORCID ↗
$10,176,242
Attributed
$17,176,694
Total exposure
11
Grants
4
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $1.5M · FY2005–25
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$17,176,694 · 11

By mechanism

R01$14,731,820 · 7
P01$2,209,346 · 3
R41$235,528 · 1

Top collaborators

Most similar at University Of California Irvine

Same institution · by research overlap

Others in their field

Top investigators on “Synapses”

Research focus

SynapsesSignal TransductionMemoryNeuronsLearningSynaptic PlasticityImpaired CognitionMediatingMutantLong-Term PotentiationBehaviorSliceHippocampus (Brain)Intellectual Functioning DisabilityAdultCognitive FunctionBrainActinsProteinsEventAcuteGene ExpressionAffectAnimals

Grant awards (51)

Postnatal Oxytocin Treatment and Cognitive Function in Fragile X$443,855
R01 · FY2025 · HD
Postnatal Oxytocin Treatment and Cognitive Function in Fragile X$82,218
R01 · FY2025 · HD
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior$618,640
R01 · FY2024 · DA
Postnatal Oxytocin Treatment and Cognitive Function in Fragile X$451,894
R01 · FY2024 · HD
Postnatal Oxytocin Treatment and Cognitive Function in Fragile X$21,060
R01 · FY2024 · HD
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior$625,964
R01 · FY2023 · DA
Postnatal Oxytocin Treatment and Cognitive Function in Fragile X$476,046
R01 · FY2023 · HD
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior$64,648
R01 · FY2023 · DA
Postnatal Oxytocin Treatment and Cognitive Function in FragileX$52,357
R01 · FY2023 · HD
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior$627,304
R01 · FY2022 · DA
Postnatal Oxytocin Treatment and Cognitive Function in Fragile X$476,046
R01 · FY2022 · HD
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior$64,648
R01 · FY2022 · DA
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior$637,516
R01 · FY2021 · DA
Postnatal Oxytocin Treatment and Cognitive Function in Fragile X$476,046
R01 · FY2021 · HD
Epigenetic mechanisms in the medial habenula governing drug-seeking behavior$640,539
R01 · FY2020 · DA
Loss and rescue of endocannabinoid-dependent LTP and memory in Fragile-X model mice$445,081
R01 · FY2020 · HD · contact PI
Loss and rescue of endocannabinoid-dependent LTP and memory in Fragile-X model mice$445,081
R01 · FY2019 · HD · contact PI
Loss and rescue of endocannabinoid-dependent LTP and memory in Fragile-X model mice$426,656
R01 · FY2018 · HD · contact PI
Convergent Synaptic Mechanisms in Neurodevelopmental Disorders$547,271
R01 · FY2017 · NS
Role of neuron-specific nucleosome remodeling in intellectual disability$436,802
R01 · FY2017 · MH
Loss and rescue of endocannabinoid-dependent LTP and memory in Fragile-X model mice$426,656
R01 · FY2017 · HD · contact PI
Convergent Synaptic Mechanisms in Neurodevelopmental Disorders$547,271
R01 · FY2016 · NS
Role of neuron-specific nucleosome remodeling in intellectual disability$467,213
R01 · FY2016 · MH
Loss and rescue of endocannabinoid-dependent LTP and memory in Fragile-X model mice$460,044
R01 · FY2016 · HD · contact PI
Role of Neuron-Specific Nucleosome Remodeling in Intellectual Disability$27,582
R01 · FY2016 · MH
Convergent Synaptic Mechanisms in Neurodevelopmental Disorders$547,271
R01 · FY2015 · NS
Role of neuron-specific nucleosome remodeling in intellectual disability$436,802
R01 · FY2015 · MH
The Spine Cytoskeleton and Memory Disorders$208,133
P01 · FY2015 · NS · contact PI
Convergent Synaptic Mechanisms in Neurodevelopmental Disorders$566,201
R01 · FY2014 · NS
Role of neuron-specific nucleosome remodeling in intellectual disability$436,688
R01 · FY2014 · MH
The Spine Cytoskeleton and Memory Disorders$208,400
P01 · FY2014 · NS · contact PI
Convergent Synaptic Mechanisms in Neurodevelopmental Disorders$586,640
R01 · FY2013 · NS
Role of neuron-specific nucleosome remodeling in intellectual disability$507,313
R01 · FY2013 · MH
The Spine Cytoskeleton and Memory Disorders$202,412
P01 · FY2013 · NS · contact PI
The Spine Cytoskeleton and Memory Disorders$215,244
P01 · FY2012 · NS · contact PI
The Spine Cytoskeleton and Memory Disorders$229,589
P01 · FY2011 · NS · contact PI
Integrins and LTP consolidation$244,612
R01 · FY2008 · NS · contact PI
Effects of Elevating Brain Derived Neurotrophic Factor on Hippocampal Physiology$269,921
P01 · FY2007 · NS · contact PI
Integrins and LTP consolidation$244,729
R01 · FY2007 · NS · contact PI
Integrins and LTP consolidation$252,156
R01 · FY2006 · NS · contact PI
Effects of Elevating Brain Derived Neurotrophic Factor on Hippocampal Physiology$221,102
P01 · FY2006 · NS · contact PI
Integrins and LTP consolidation$281,466
R01 · FY2005 · NS
Effects of Elevating Brain Derived Neurotrophic Factor on Hippocampal Physiology$214,432
P01 · FY2005 · NS
Kinase Inhibitors against Neurodegeneration$235,528
R41 · FY2004 · NS
Effects of Elevating Brain Derived Neurotrophic Factor on Hippocampal Physiology$203,793
P01 · FY2004 · NS
Effects of Elevating Brain Derived Neurotrophic Factor on Hippocampal Physiology$236,320
P01 · FY2003 · NS
Integrin and LTP Consolidation$208,968
R01 · FY2003 · MH
Integrin and LTP Consolidation$208,968
R01 · FY2002 · MH
Lysosomal Dysfunction and AD Pathology: Role of AB$0
P01 · FY2002 · AG
Integrin and LTP Consolidation$221,568
R01 · FY2001 · MH
Lysosomal Dysfunction and AD Pathology: Role of AB$0
P01 · FY2001 · AG